Janssen Pharmaceutica
Janssen Pharmaceutica is a Public Limited Company registered in Belgium under 0403834160, and its current status with Crossroads Bank for Enterprises (KBO/BCE) is active. The company was incorporated on 23 October 1934 and lists its registered address as Belgium. 2 shareholders are on record for Janssen Pharmaceutica, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last updated on 30 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of Janssen Pharmaceutica
Two shareholders are currently on record for Janssen Pharmaceutica, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is Johnson & Johnson, holding 100% — a majority holding — followed by Johnson & Johnson International at 0%. 1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Johnson & Johnson | 100% | Crossroads Bank for Enterprises (KBO/BCE) | |
| Johnson & Johnson International | 0% | Crossroads Bank for Enterprises (KBO/BCE) |
Officers
5
Directors and officers of Janssen Pharmaceutica
The Director of Janssen Pharmaceutica currently on record is Dirk Collier; five officers are currently on record for Janssen Pharmaceutica, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Janssen Pharmaceutica sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 20 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Group Structure
Group structure of Janssen Pharmaceutica
Janssen Pharmaceutica sits 1 level below its ultimate parent, Johnson & Johnson, registered in United States. 10 subsidiaries are recorded beneath it, across 7 jurisdictions. Immediately above Janssen Pharmaceutica is Johnson & Johnson, holding 100% as filed in Janssen Pharmaceutica's own shareholder record with Crossroads Bank for Enterprises (KBO/BCE). Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Janssen Pharmaceutica Nv (Norway)
- Janssen Pharmaceutica NV (Finland)
- Janssen-Cilag International (Belgium)
- OMRIX BIOPHARMACEUTICALS LTD (Israel)
- JOHNSON & JOHNSON SDN BHD (Malaysia)
- Janssen-Cilag (Belgium)
- JANSSEN CILAG SPA (Italy)
- J.C.General Services (Belgium)
- Janssen Pharmaceutica Nv (Sweden)
- JNTL (MALAYSIA) SDN. BHD. (Malaysia)
Data availability
Those 10 subsidiaries span Belgium, Norway, Finland, Israel, Malaysia, Italy, and 1 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Data-provider feed — rows as supplied to Zavia for Crossroads Bank for Enterprises (KBO/BCE), including entries the profile above does not cover. These rows are not a verbatim copy of the register: they have been found to duplicate the same person under different spellings and to keep a status of Active after an appointment ended. Where they disagree with the profile above, the profile is the checked version.
Johnson & Johnson
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Janssen Pharmaceutica?
Two shareholders are currently on record for Janssen Pharmaceutica, reflecting the registre des actions nominatives (register of registered shares) maintained under the Code des sociétés et des associations rather than a public filing. The largest of these is Johnson & Johnson, holding 100% — a majority holding — followed by Johnson & Johnson International at 0%. 1 shareholder shown is a company, so the ownership chain continues above this level for that holding; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is Janssen Pharmaceutica's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Janssen Pharmaceutica is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Janssen Pharmaceutica have on record?
2 shareholders are shown on record for Janssen Pharmaceutica.
What is Janssen Pharmaceutica's company registration number?
Janssen Pharmaceutica's registration number is 0403834160, filed with Crossroads Bank for Enterprises (KBO/BCE) in Belgium. Its current status on the register is active.
Is Janssen Pharmaceutica still an active company?
Janssen Pharmaceutica's status on Crossroads Bank for Enterprises (KBO/BCE) is listed as active.
When was Janssen Pharmaceutica incorporated?
Janssen Pharmaceutica was incorporated on 23 October 1934, according to Crossroads Bank for Enterprises (KBO/BCE).
What is Janssen Pharmaceutica's registered address?
The registered address on file for Janssen Pharmaceutica is Belgium.
What legal structure is Janssen Pharmaceutica registered as?
Janssen Pharmaceutica is registered as a Public Limited Company in Belgium.
Who are the officers/directors of Janssen Pharmaceutica?
The Director of Janssen Pharmaceutica currently on record is Dirk Collier; five officers are currently on record for Janssen Pharmaceutica, filed with Crossroads Bank for Enterprises (KBO/BCE). Management authority at Janssen Pharmaceutica sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Janssen Pharmaceutica have a parent company or subsidiaries?
Janssen Pharmaceutica sits 1 level below its ultimate parent, Johnson & Johnson, registered in United States. 10 subsidiaries are recorded beneath it, across 7 jurisdictions. Those 10 subsidiaries span Belgium, Norway, Finland, Israel, Malaysia, Italy, and 1 more jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Janssen Pharmaceutica's ownership over time?
This profile reflects a point-in-time snapshot from Crossroads Bank for Enterprises (KBO/BCE). Zavia's monitoring API can track changes to Janssen Pharmaceutica's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Janssen Pharmaceutica's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Belgium, so records like Janssen Pharmaceutica's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Crossroads Bank for Enterprises (KBO/BCE) and was last synced on 30 September 2026.